Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer

被引:14
|
作者
Kim, Hee Jun [1 ]
Kim, Yu Jung [1 ]
Seo, Myung-Deok [1 ]
Yi, Hyeon Gyu [1 ]
Lee, Se-Hoon [1 ,2 ]
Lee, Sang-Min [1 ]
Kim, Dong-Wan [1 ,2 ]
Yang, Seok-Chul [1 ]
Lee, Choon-Taek [1 ]
Lee, Jong Seok [1 ]
Kim, Young-Whan [1 ]
Heo, Dae Seog [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam 463707, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Songnam 463707, Gyeonggi Do, South Korea
关键词
Advanced NSCLC; Palliative procedure; CARE;
D O I
10.1016/j.lungcan.2008.11.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Despite recent progress in palliative chemotherapy for advanced non-small cell lung cancer (NSCLC), the prognosis is still poor. Aside from multiple lines of chemotherapy, many patients need palliative procedures due to disease-related events. The patterns of events requiring palliative procedures and their impact on the clinical course have not been well described. Methods: We evaluated 162 patients who were diagnosed with stage IIIB (with malignant effusion) or IV NSCLC at Seoul National University Hospital in 2005. The patterns of disease-related events requiring palliative procedures, the palliative procedures given, and the clinical outcomes were retrospectively analyzed. Results: Of the 162 patients, 107 were male (66%) and 55 were female (34%) with a median age of 61 years (range 31-90). Among these patients, 108 patients (66%) received palliative procedures due to disease-related events. Forty-nine patients (30%) needed a palliative procedure at the time of diagnosis, and 59 patients (36%) required palliative procedure later during the course of their treatment. The events requiring palliative procedures were thoracic events (malignant effusion or severe pneumonia requiring intensive care unit care not related to treatment) in 32 (30%), CNS events (brain metastasis or leptomeningeal metastasis) in 37 (34%), skeletal events (bone metastasis requiring radiation, spinal cord compression, hypercalcemia) in 29 (27%), and other events in 10 (9%). The patients who had events at the time of diagnosis showed comparable overall survival to the patients without events at the time of diagnosis (14.6 months vs. 13.3 months, p = 0.65). The patients with later events during their course of treatment had a short median survival after the event requiring palliative procedures (median 2.7 months, 95% CI 2.19-3.21). Conclusion: A considerable proportion of patients with advanced NSCLC receive palliative procedures apart from chemotherapy. These interventions should be taken into consideration for comprehensive cancer care and timely cooperation with palliative care team. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 50 条
  • [1] Patterns of palliative procedures and clinical outcome in advanced non-small cell lung cancer
    Kim, Y.
    Kim, H. J.
    Seo, M.
    Yi, H.
    Lee, S.
    Kim, D.
    Heo, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Palliative treatment for advanced non-small cell lung cancer
    Macbeth, F
    Stephens, R
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 115 - +
  • [3] Clinical outcomes for immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Jia, Wenxiao
    Wang, Min
    Zhu, Hui
    Wu, Gang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Palliative care for patients with locally advanced and metastatic non-small cell lung cancer
    Simone, Charles B., II
    Jones, Joshua A.
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (04) : 178 - 188
  • [5] Surgical Outcomes of Patients with Locally Advanced Non-small Cell Lung Cancer
    Lushaj, E.
    Jaoude, W. Abi
    Macke, R.
    Maloney, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S34 - S35
  • [6] CHARACTERISTICS AND OUTCOMES OF ADVANCED NON-SMALL CELL LUNG CANCER OF THE YOUNG PATIENTS
    Sakata, Hiroshi
    Kojima, Keisuke
    Sakata, Shinya
    Saeki, Sho
    Masunaga, Aiko
    Mizokami, Yuko
    Ideguchi, Hideharu
    Horio, Yuko
    Saruwatari, Kouichi
    Okamoto, Shinichiro
    Hirosako, Susumu
    Ichiyasu, Hidenori
    Fujii, Kazuhiko
    Kohrogi, Hirotsugu
    [J]. RESPIROLOGY, 2013, 18 : 83 - 83
  • [7] Clinical outcomes of nab-paclitaxel for advanced or relapsed non-small cell lung cancer patients
    Manabe, Saki
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Yamada, Kouzo
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 124 - 124
  • [8] Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Lan
    Li, Li
    Zhou, Yingxu
    Yang, Zhaoyang
    Wang, Meng
    Gao, Yina
    Yang, Yang
    Yang, Fang
    Liu, Bao
    Hong, Xuan
    Chen, Gongyan
    [J]. JOURNAL OF CANCER, 2020, 11 (24): : 7137 - 7145
  • [9] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [10] Referrals for Palliative Care and Hospice Are Underutilized in Patients with Advanced Non-Small Cell Lung Cancer
    Rayburn, J. R.
    Wilshire, C. L.
    Gilbert, C. R.
    Louie, B. E.
    Aye, R. W.
    Farivar, A. S.
    Vallieres, E.
    Gorden, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197